Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.
Monte-Mor Bda C, Ayres-Silva Jde P, Correia WD, Coelho AC, Solza C, Daumas AH, Bonamino MH, Santos FP, Datoguia TS, Pereira Wde O, Lisboa BC, Ramos CF, Machado-Neto JA, Hamerschlak N, Campregher PV, Traina F, Pagnano KB, Zalcberg I. Monte-Mor Bda C, et al. Blood Cells Mol Dis. 2016 Sep;60:74-7. doi: 10.1016/j.bcmd.2016.03.003. Epub 2016 Mar 8. Blood Cells Mol Dis. 2016. PMID: 26994960 Clinical Trial. No abstract available.
Chromomycin A5 induces bona fide immunogenic cell death in melanoma.
Florêncio KGD, Edson EA, Fernandes KSDS, Luiz JPM, Pinto FDCL, Pessoa ODL, Cunha FQ, Machado-Neto JA, Wilke DV. Florêncio KGD, et al. Front Immunol. 2022 Nov 9;13:941757. doi: 10.3389/fimmu.2022.941757. eCollection 2022. Front Immunol. 2022. PMID: 36439184 Free PMC article.
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.
Tavares MT, Krüger A, Yan SLR, Waitman KB, Gomes VM, de Oliveira DS, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Hassimotto NMA, Machado-Neto JA, Poso A, Cameron MD, Bannister TD, Palmisano G, Wrenger C, Kronenberger T, Parise-Filho R. Tavares MT, et al. Sci Rep. 2023 Nov 29;13(1):21006. doi: 10.1038/s41598-023-47959-z. Sci Rep. 2023. PMID: 38030668 Free PMC article.
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Pereira-Martins DA, da Silva WF, Cavaglieri RC, Nardinelli L, Leal AM, Velloso EDRP, Bendit I, Câmara NOS, Schuringa JJ, Machado-Neto JA, Rego EM. Lima K, et al. Eur J Pharmacol. 2024 Aug 15;977:176723. doi: 10.1016/j.ejphar.2024.176723. Epub 2024 Jun 6. Eur J Pharmacol. 2024. PMID: 38851560
121 results